EyeBio
USEntry
2022
Hold
2yr
Exit
2024
Who owns EyeBio?
EyeBio was owned by Jeito Capital through Jeito I (2021 vintage) from 2022 to 2024, exited via Trade Sale. Across its history, EyeBio has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Key takeaways
- ·Fully exited in 2024.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2024 to .
Co-invest · 2 holders · 2021 · 2024
SV Health ManagersExited 2024
2021 · 2024(3yr) · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
Trade Sale · to
MOIC
–
More from Jeito I
Other portfolio companies in the same fund.
France
Switzerland
Spain
Germany
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track EyeBio
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy EyeBio?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on EyeBio.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue